Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 2.88% | 3.53% | 13.90% | 1.71% | 2.45% |
| Total Depreciation and Amortization | -36.78% | -43.26% | -32.85% | -28.36% | -18.26% |
| Total Amortization of Deferred Charges | 1,370.18% | 67,500.00% | -- | -- | -- |
| Total Other Non-Cash Items | -44.35% | -35.85% | -48.20% | -38.74% | -48.76% |
| Change in Net Operating Assets | 1,063.79% | 169.88% | -162.67% | 2,072.73% | 103.01% |
| Cash from Operations | 0.24% | 9.35% | -2.79% | -4.74% | -6.14% |
| Capital Expenditure | -37.14% | 50.26% | 79.75% | 90.75% | 87.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.68% | -71.46% | 27.92% | 159.22% | 163.10% |
| Cash from Investing | -46.97% | -71.67% | 32.14% | 157.86% | 161.87% |
| Total Debt Issued | -0.99% | -0.99% | 4,306.49% | 4,306.49% | -- |
| Total Debt Repaid | -203.07% | 24.12% | -61.96% | -38.54% | 3.16% |
| Issuance of Common Stock | -98.63% | -98.13% | -46.60% | -39.99% | -97.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 80.22% | -6,740.00% | -970.97% | -878.57% |
| Cash from Financing | -25.83% | -18.62% | 962.18% | 1,035.54% | -85.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,021.87% | -776.35% | 98.16% | 108.75% | -93.28% |